{
    "Symbol": "DGX",
    "AssetType": "Common Stock",
    "Name": "Quest Diagnostics Incorporated",
    "Description": "Quest Diagnostics is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe.",
    "CIK": "1022079",
    "Exchange": "NYSE",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "LIFE SCIENCES",
    "Industry": "SERVICES-MEDICAL LABORATORIES",
    "Address": "500 PLAZA DRIVE, SECAUCUS, NJ, US",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2023-03-31",
    "MarketCapitalization": "15529770000",
    "EBITDA": "1989000000",
    "PERatio": "16.15",
    "PEGRatio": "1.237",
    "BookValue": "53.09",
    "DividendPerShare": "0",
    "DividendYield": "0.0205",
    "EPS": "6.77",
    "RevenuePerShareTTM": "85.2",
    "ProfitMargin": "0",
    "OperatingMarginTTM": "0",
    "ReturnOnAssetsTTM": "0.0734",
    "ReturnOnEquityTTM": "12.7",
    "RevenueTTM": "9883000000",
    "GrossProfitTTM": "3467000000",
    "DilutedEPSTTM": "6.83",
    "QuarterlyEarningsGrowthYOY": "-0.717",
    "QuarterlyRevenueGrowthYOY": "-0.15",
    "AnalystTargetPrice": "149.67",
    "TrailingPE": "20.32",
    "ForwardPE": "17.48",
    "PriceToSalesRatioTTM": "1.651",
    "PriceToBookRatio": "2.76",
    "EVToRevenue": "2.055",
    "EVToEBITDA": "9.59",
    "Beta": "0.941",
    "52WeekHigh": "156.85",
    "52WeekLow": "118.63",
    "50DayMovingAverage": "140.18",
    "200DayMovingAverage": "139.97",
    "SharesOutstanding": "112000000",
    "DividendDate": "2023-04-24",
    "ExDividendDate": "2023-04-06"
}